The German pharmaceutical company Merck, together with other international companies in the same line of business, plan to launch a fund that will invest 20 million euros ($24.6 million) in Israeli biotechnology over the next five years.
The full article appears in the April 2018 issue of Israel Today Magazine.
CLICK HERE to read it now >>
Not yet a subscriber to our digital magazine? Get an annual subscription now at only $20.99 for a limited time